ckd glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Real-World Evidence for GLP-1 Receptor

The purpose of our study was to explore the long-term effects of anti-obesity medications (AOMs) on body weight and to draw the trajectory of weight change after discontinuation of AOMs

Planning a pregnancy on a GLP-1

WEGOVY(semaglutide) injection 2.4 mg is an injectable prescription medicine that may help adults and children aged 12 years with obesity (BMI 30 for adults, BMI 95th percentile for age and sex for children), or some adults with excess weight (BMI 27) (overweight) who also have weight-related medical problems to

Features Akkermansia muciniphila, a key component of a balanced gut microbiome

Evidence shows some regain after stopping GLP-1s

Chemist4U surveyed more than 3,500 UK adults to find out how they feel about weight loss, injections, and the arrival of these tablets.